Skip to main content

Pediatric Drug-Resistant Pulmonary Tuberculosis

  • Chapter
  • First Online:
Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis

Abstract

It was pointed out by WHO global tuberculosis report 2022 [1] that there were about 10.6 million newly diagnosed cases of tuberculosis worldwide in 2021, 1.2 million of which were children, accounting for 11%. 217,000 children died of tuberculosis in the same year, accounting for about 14% of the world’s deaths due to tuberculosis. The greater proportion of pediatric deaths than the estimated proportion suggests that children with tuberculosis have a lower chance to establish the diagnosis and acquire treatment. The report also pointed out that, the cumulative number of pediatric MDR/RR-TB patients registered for treatment between 2018 and 2021 was 17,700, only 15% of the global 5-year target of 115,000 from 2018 to 2022, which was set by the United Nations High level Conference. Some studies [2] have pointed out that there have been about 25,000–32,000 newly increased pediatric MDR-TB cases worldwide per year and the actual prevalence may be 12 times of the existing patients with confirmed diagnosis, through evaluating the incidence of pediatric MDR-TB by using MDR-TB risk model based on the integration of various global data. Pediatric drug-resistant tuberculosis tends to raise the rate of severe cases and mortality, especially in infants and young children (below 3 years old) prone to miliary tuberculosis and/or tuberculosis meningitis, and it would progress very easily from infection with tubercle bacillus because of their immaturely developed immune organs [3]. Characterized by high expenditure and multiple drugs required by the prolonged medication with adverse reaction commonly observed [4–6], pediatric drug-resistant tuberculosis can also become an important infectious source of drug-resistant tuberculosis [7]. Fortunately, the treatment success rate can reach to 78–90% [4, 8, 9], if the drug-resistant tuberculosis can be diagnosed in the early stage with treatment provided timely, owing to the low TB load in children. Diagnosis in early stage, therefore, seems to be the key link to cure pediatric drug-resistant tuberculosis. However, difficulties in acquiring etiological evidences for this disease predispose its diagnosis to a great challenge, making image examination become extremely important and likely the unique method, especially CT scans endowed with an overwhelming significance in clinical imaging diagnosis, differential diagnosis, and evaluation of responses and prognosis in pediatric population with this disease [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. Global tuberculosis report 2022 [EB/OL]. http://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosisreport-2022.

  2. Jenkins HE, Yuen CM. The burden of multi-drug resistant tuberculosis in children [J]. Int J Tuberc Lung Dis. 2018;22(5):3–6.

    Article  CAS  PubMed  Google Scholar 

  3. Donald PR, Marais BJ, Barry CE. Age and the epidemiology and pathogenesis of tuberculosis [J]. Lancet 2010;375(9729):1852–1854.

    Google Scholar 

  4. Harausz EP, Garcia-Prats AJ, Law S, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis [J]. PLoS Med. 2018;15(7):e1002591.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Li J, Shen A. The burden and harm of pediatric drug-resistant tuberculosis [J]. Chin J Antituberc. 2018;40(9):989–92.

    Google Scholar 

  6. Marquez L, Starke JR. Diagnosis and management of TB in children: an update [J]. Expert Rev Anti Infect Ther. 2011;9(12):1157–68.

    Article  PubMed  Google Scholar 

  7. Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation [J]. Lancet Infect Dis. 2017;17(3):275–84.

    Article  CAS  PubMed  Google Scholar 

  8. Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multi-drug resistant, extensively drug-resistant, and incurable tuberculosis [J]. Lancet Respir Med. 2017;5(4):291–360.

    Article  Google Scholar 

  9. Liao Q, Tan S, Zhu Y, et al. Clinical characteristics of pediatric drug-resistant tuberculosis and analysis of the effect of the second-line anti-tuberculosis treatment [J]. Chin J Pediatrics. 2017;55(2):100–3.

    CAS  Google Scholar 

  10. Yu W, Tan W-g, Lu P-x. Classification and imaging manifestations of drug-resistant pulmonary tuberculosis [J/CD]. Electr J Emerg Infect Dis. 2019;4(1):42–7.

    Google Scholar 

  11. Shen A, Jiao W. Status of epidemics and drug resistance in pediatric tuberculosis [J]. Chin J Appl Clin Pediatrics. 2016;31(4):269–71.

    Google Scholar 

  12. World Health Organization. Global tuberculosis report 2012 [M]. Who/HTM/TB/2012.6. Geneva: WHO Press; 2012. p. 49.

    Google Scholar 

  13. World Health Organization. Global Tuberculosis Report 2015 [M]. Who/HTM/TB/2015.22. Geneva: WHO Press; 2015. p. 32.

    Google Scholar 

  14. Zignol M, Sismanidis C, Falzon D, et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance [J]. Eur Respir J. 2013;42(3):701–7.

    Article  PubMed  Google Scholar 

  15. Zhao Y, Xu S, Wang L, et al. National survey of drug resistant tuberculosis in China [J]. N Engl J Med. 2012;366(23):2161–70.

    Article  CAS  PubMed  Google Scholar 

  16. Jiao WW, Liu ZG, Han R, et al. Prevalence of drug resistant mycobacterium tuberculosis among children in China [J]. Tuberculosis (Edinb). 2015;95(3):315–20.

    Article  PubMed  Google Scholar 

  17. Peng Z, Liu R, Li Q, et al. An analysis of drug resistance status and risk factors of pediatric tuberculosis [J]. Chin J Microecol. 2011;23(7):644–6.

    Google Scholar 

  18. Li T, Lu S. Analysis of pediatric drug-resistant tuberculosis [C]. Chongqing: Tuberculosis Branch of Chinese Medical Association; 2013.

    Google Scholar 

  19. Huang Q, Li K, Yu Z, et al. An analysis on epidemiological and drug-resistance characteristics in 458 cases of pediatric tuberculosis in Wuhan from 2013 to 2015 [J]. Pract Prev Med. 2017;24:1511–3.

    Google Scholar 

  20. Ning-Ning T, Xiao-Chun H, Xian-Xin Z, et al. Drug-resistant tuberculosis among children, China, 2006–2015 [J]. Emerg Infect Dis. 2017;23(11):1800–5.

    Article  Google Scholar 

  21. Macias Parra M, Kumate Rodriguez J, Arredondo Garcia JL, et al. Mycobacterium tuberculosis complex genotype diversity and drug resistance profiles in a pediatric population in Mexico [J]. Tuberc Restreat. 2011;2011(2011):7–15.

    Google Scholar 

  22. Nelson LJ, Schneider E, Wells CD, et al. Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance [J]. Pediatrics. 2004;114(2):333–41.

    Article  PubMed  Google Scholar 

  23. Fairlie L, Beykis NC, Reubenson G, et al. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study [J]. BMC Infect Dis. 2011;11:28.

    Article  PubMed  PubMed Central  Google Scholar 

  24. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children [M]. 2nd ed. Geneva: World Health Organization; 2014. p. 65–74.

    Google Scholar 

  25. Guo Z. Observation on the recent efficacy of cycloserine in pediatric drug-resistant tuberculosis [J]. Contemp Med. 2019;24(19):102–4.

    Google Scholar 

  26. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era [J]. Int J Tuberc Lung Dis. 2004;8(4):392–402.

    CAS  PubMed  Google Scholar 

  27. Wang Y, Zhao S, Yu T, et al. An analysis on clinical features of pediatric tuberculosis based on CT typing method [J]. Chin J Antituberc. 2018;9:940–3.

    Google Scholar 

  28. Wan C. Diagnosis and treatment of drug-resistant mycobacterium tuberculosis infection in children [J]. J Appl Clin Pediatrics. 2010;25(10):703–6.

    Google Scholar 

  29. Manikkam S, Archary N, Bobat R. Chest X-ray patterns of pulmonary multidrug-resistant tuberculosis in children in a high HIV-prevalence setting [J]. SA J Radiol. 2016;20(1):1–6.

    Google Scholar 

  30. Xin D, Xin J. An analysis of CT manifestations of pediatric secondary pulmonary tuberculosis [J]. Chin J Antituberc. 2018;40(9):1003–6.

    Google Scholar 

  31. Cen W, Chen P, Liao C, et al. An analysis on clinical features and treatment in 320 cases of tracheobronchial tuberculosis [J]. Guangdong Med. 2013;34(16):2508–10.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fang, Wj., Song, M., Han, Yy., Xu, Cj., Yi, Yx., Lu, Sh. (2023). Pediatric Drug-Resistant Pulmonary Tuberculosis. In: Lu, PX., Lu, Hz., Yi, Yx. (eds) Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis. Springer, Singapore. https://doi.org/10.1007/978-981-99-8339-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-8339-1_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-8338-4

  • Online ISBN: 978-981-99-8339-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics